Carven Setiawan: The Future of Haemostasis Is Proactive – Reflections from APHEAM 2026
Carven Setiawan, Senior Manager, Professional Education, Ethicon Asia Pacific Johnson & Johnson MedTech, shared a post on LinkedIn:
“As the excitement and adrenaline from APHEAM 2026 subsided, I took the opportunity to reflect on the experience.
The 2026 Asia Pacific Hemostasis Ed Advisory Meeting (APHEAM 2026) highlighted a shift from reactive bleeding control to a proactive, patient-centred haemostasis pathway.
Exactly 2 weeks ago, close to 70 healthcare professionals from across Asia Pacific gathered together to exchange real-world clinical experience, share best practice and learn from one another.
Many topics were discussed, debated and exchanged.
These 3 things particularly stayed with me:
- Haemostasis begin before the first incision. Effective bleeding management is not a product decision made in the OR. The consensus across specialties was that anticipation is more effective than rescue.
- Successful Haemostasis depends on clinical judgement and preparation. This underscores the opportunity for Johnson & Johnson MedTech to move beyond products but as an education partner facilitating evidence-based education and clinical best practice sharing.
- I witnessed and admired the remarkable commitments of participating HCPs to continually refine their practice through learning, reflection, and collaboration. This culture of knowledge exchange is essential to driving better surgical outcomes and improving quality of patient care.
I’m incredible thankful to the Scientific Committee Members for your partnership in shaping the scientific agenda and for the camaraderie of my colleagues who played various roles in making APHEAM 2026 a success.
You know who you are.
Thank you.”
See more in the gallery.
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC